Assessing particle and fiber toxicology in the respiratory system: The stereology toolbox

Particle and Fibre Toxicology

Volumn 12, Issue 1, 2015, Pages

  Brandenberger, Christina ^a,b   Ochs, Matthias ^a,b,c   Mühlfeld, Christian ^a,b,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy)   (Germany)

^c German Center for Lung Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; BROXURIDINE; CARBON NANOTUBE; SILICA NANOPARTICLE; SILVER NANOPARTICLE; TITANIUM DIOXIDE NANOPARTICLE; PARTICULATE MATTER;

AIRBORNE PARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; ECOTOXICOLOGY; ENVIRONMENTAL EXPOSURE; EXHAUST GAS; HISTOPATHOLOGY; HUMAN; INJURY SEVERITY; LONG TERM EXPOSURE; LUNG ALVEOLUS; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG PARENCHYMA; LUNG VOLUME; MATHEMATICAL MODEL; METAPLASIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT INJURY; RESPIRATORY TRACT TUMOR; REVIEW; STEREOMETRY; TOXIC INHALATION; DRUG EFFECTS; PARTICULATE MATTER; PATHOLOGY; RESPIRATORY SYSTEM; TOXICITY;

HUMANS; PARTICULATE MATTER; RESPIRATORY SYSTEM;

EID: 84946499136     PISSN: 17438977     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/s12989-015-0110-8     Document Type: Review

References (101)

1. Hinkley GK, Roberts SM. Particle and Fiber Toxicology. In: Merkus HG, Meesters GMH, editors. Particulate Products: Tailoring Properties for Optimal Performance. Switzerland: Springer International Publishing AG; 2014. p. 153-85.
2. Bakand S, Hayes A, Dechsakulthorn F. Nanoparticles: a review of particle toxicology following inhalation exposure. Inhal Toxicol. 2012;24:125-35.
3. Schwarze PE, Ovrevik J, Låg M, Refsnes M, Nafstad P, Hetland RB, et al. Particulate matter properties and health effects: consistency of epidemiological and toxicological studies. Hum Exp Toxicol. 2006;25:559-79.
4. Maynard AD, Kuempel ED. Airborne nanostructured particles and occupational health. J Nanopart Res. 2005;7:587-614.
5. Maynard AD, Warheit DB, Philbert MA. The new toxicology of sophisticated materials: nanotoxicology and beyond. Toxicol Sci. 2011;120 SUPPL. 1:109-29.
6. Oyama T, Ishikawa Y, Hayashi M, Arihiro K, Horiguchi J. The effects of fixation, processing and evaluation criteria on immunohistochemical detection of hormone receptors in breast cancer. Breast Cancer. 2007;14:182-8.
7. Lawrie CH, Ballabio E, Soilleux E, Sington J, Hatton CSR, Dirnhofer S, et al. Inter- and intra-observational variability in immunohistochemistry: A multicentre analysis of diffuse large B-cell lymphoma staining. Histopathology. 2012;61:18-25.
8. Hsia CCW, Hyde DM, Ochs M, Weibel ER. An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. Am J Respir Crit Care Med. 2010;181:394-418.
9. Weibel ER. Stereological Methods: Theoretical Foundations, vol. 2. London: Academic; 1980.
10. Weibel ER, Gomez M. Architecture of the human lung. Science. 1962;137:577-85.
11. Weibel ER, Hsia CCW, Ochs M. How much is there really? Why stereology is essential in lung morphometry. J Appl Physiol. 2007;102:459-67.
12. Weibel ER. A retrospective of lung morphometry: from 1963 to present. Am J Physiol Lung Cell Mol Physiol. 2013;305:405-8.
13. Mühlfeld C, Ochs M. Quantitative microscopy of the lung: a problem-based approach. Part 2: stereological parameters and study designs in various diseases of the respiratory tract. Am J Physiol Lung Cell Mol Physiol. 2013;305:205-21.
14. Ochs M, Mühlfeld C. Quantitative microscopy of the lung: a problem-based approach. Part 1: basic principles of lung stereology. Am J Physiol Lung Cell Mol Physiol. 2013;305:15-22.
15. U.S. Department of Health and Human Service, Food and Drug Administration, Center for Drug Evaluation and Research: Guidance for Industry: Use of Histology in Biomarker Qualification Studies [ http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm ].
16. Boyce JT, Boyce RW, Gundersen HJ. Choice of morphometric methods and consequences in the regulatory environment. Toxicol Pathol. 2010;38:1128-33.
17. Morfeld P, Bruch J, Levy L, Ngiewih Y, Chaudhuri I, Muranko HJ, et al. Translational toxicology in setting occupational exposure limits for dusts and hazard classification - a critical evaluation of a recent approach to translate dust overload findings from rats to humans. Part Fibre Toxicol. 2015;12:3.
18. Braakhuis HM, Park MVDZ, Gosens I, De Jong WH, Cassee FR. Physicochemical characteristics of nanomaterials that affect pulmonary inflammation. Part Fibre Toxicol. 2014;11:18.
19. Salvi S, Blomberg A, Rudell B, Kelly F, Sandström T, Holgate ST, et al. Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med. 1999;159:702-9.
20. Nemmar A, Hoylaerts MF, Hoet PHM, Vermylen J, Nemery B. Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol Appl Pharmacol. 2003;186:38-45.
21. Braakhuis HM, Gosens I, Krystek P, Boere J, Cassee FR, Fokkens P, et al. Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles. Part Fibre Toxicol. 2014;11:49.
22. Baisch BL, Corson NM, Wade-Mercer P, Gelein R, Kennell AJ, Oberdörster G. Equivalent titanium dioxide nanoparticle deposition by intratracheal instillation and whole body inhalation: the effect of dose rate on acute respiratory tract inflammation. Part Fibre Toxicol. 2014;11:5.
23. Ma-Hock L, Strauss V, Treumann S, Küttler K, Wohlleben W, Hofmann T, et al. Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black. Part Fibre Toxicol. 2013;10:23.
24. Peeters PM, Eurlings IMJ, Perkins TN, Wouters EF, Schins RPF, Borm PJA, et al. Silica-induced NLRP3 inflammasome activation in vitro and in rat lungs. Part Fibre Toxicol. 2014;11:58.
25. Donaldson K, Brown GM, Brown DM, Bolton RE, Davis JM. Inflammation generating potential of long and short fibre amosite asbestos samples. Bri J Ind Med. 1989;46:271-6.
26. MacNee W, Donaldson K. Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD. Eur Respir J. 2003;21 SUPPL. 40:47-51.
27. Yoshida T, Tuder R. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev. 2007;87:1047-82.
28. Cullinan P. Occupation and chronic obstructive pulmonary disease (COPD). Br Med Bull. 2012;104:143-61.
29. Kim JJ, Huen K, Adams S, Smorodinsky S, Hoats A, Malig B, et al. Residential traffic and children's respiratory health. Env Heal Perspect. 2008;116:1274-9.
30. Young MT, Sandler DP, DeRoo LA, Vedal S, Kaufman JD, London SJ. Ambient air pollution exposure and incident adult asthma in a nationwide cohort of U.S. women. Am J Respir Crit Care Med. 2014;190:914-21.
31. Li N, Harkema JR, Lewandowski RP, Wang M, Bramble LA, Gookin GR, et al. Ambient ultrafine particles provide a strong adjuvant effect in the secondary immune response: implication for traffic-related asthma flares. Am J Physiol Lung Cell Mol Physiol. 2010;299:374-83.
32. Takahashi G, Tanaka H, Wakahara K, Nasu R, Hashimoto M, Miyoshi K, et al. Effect of diesel exhaust particles on house dust mite-induced airway eosinophilic inflammation and remodeling in mice. J Pharmacol Sci. 2010;112:192-202.
33. Brandenberger C, Rowley NL, Jackson-Humbles DN, Zhang Q, Bramble LA, Lewandowski RP, et al. Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice. Part Fibre Toxicol. 2013;10:26.
34. Ban M, Langonné I, Huguet N, Guichard Y, Goutet M. Iron oxide particles modulate the ovalbumin-induced Th2 immune response in mice. Toxicol Lett. 2013;216:31-9.
35. Taskar VS, Coultas DB. Is idiopathic pulmonary fibrosis an environmental disease? Proc Am Thorac Soc. 2006;3:293-8.
36. Cohen RAC, Patel A, Green FHY. Lung disease caused by exposure to coal mine and silica dust. Semin Respir Crit Care Med. 2008;29:651-61.
37. Chen T, Nie H, Gao X, Yang J, Pu J, Chen Z, et al. Epithelial-mesenchymal transition involved in pulmonary fibrosis induced by multi-walled carbon nanotubes via TGF-beta/Smad signaling pathway. Toxicol Lett. 2014;226:150-62.
38. Ma JY, Mercer RR, Barger M, Schwegler-Berry D, Scabilloni J, Ma JK, et al. Induction of pulmonary fibrosis by cerium oxide nanoparticles. Toxicol Appl Pharmacol. 2012;262:255-64.
39. Hecht SS. Tobacco smoke carcinogens and lung cancer. Cur Cancer Res. 2011;6:53-74.
40. Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 2000;44:565-601.
41. Weill H, McDonald JC. Exposure to crystalline silica and risk of lung cancer: the epidemiological evidence. Thorax. 1996;51:97-102.
42. Li N, Wang M, Bramble LA, Schmitz DA, Schauer JJ, Sioutas C, et al. The adjuvant effect of ambient particulate matter is closely reflected by the particulate oxidant potential. Env Heal Perspect. 2009;117:1116-23.
43. Chen C, Chan C, Chen B, Cheng T, Leon Y. Effects of particulate air pollution and ozone on lung function in non-asthmatic children. Env Res. 2015;137:40-8.
44. Sun L, Liu C, Xu X, Ying Z, Maiseyeu A, Wang A, et al. Ambient fine particulate matter and ozone exposures induce inflammation in epicardial and perirenal adipose tissues in rats fed a high fructose diet. Part Fibre Toxicol. 2013;10:43.
45. De Haar C, Kool M, Hassing I, Bol M, Lambrecht BN, Pieters R. Lung dendritic cells are stimulated by ultrafine particles and play a key role in particle adjuvant activity. J Allergy Clin Immunol. 2008;121:1246-54.
46. Nygaard UC, Aase A, Løvik M. The allergy adjuvant effect of particles - genetic factors influence antibody and cytokine responses. BMC Immunol. 2005;6:11.
47. Hyde DM, Hamid Q, Irvin CG. Anatomy, pathology, and physiology of the tracheobronchial tree: emphasis on the distal airways. J Allergy Clin Immunol. 2009;124:72-7.
48. Hyde DM, Magliano DJ, Plopper CG. Morphometric assessment of pulmonary toxicity in the rodent lung. Toxicol Pathol. 1991;19:673-4.
49. Fehrenbach H. Morphological quantitation of emphysema: a debate. J Appl Physiol. 2006;100:1423-4.
50. Ochs M. Estimating structural alterations in animal models of lung emphysema. Is there a gold standard? Ann Anat. 2014;196:26-33.
51. Moore BBHC. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2008;294:152-60.
52. Kuhn C. Pathology of pulmonary fibrosis. In: Phan S, Thrall R, editors. Pulmonary Fibrosis. New York: Marcel Dekker; 1995. p. 83.
53. Williams KJ, Robinson NE, Lim A, Brandenberger C, Maes R, Behan A, et al. Experimental induction of pulmonary fibrosis in horses with the gammaherpesvirus equine herpesvirus 5. PLoS One. 2013;8:1-15.
54. Mühlfeld C, Poland C, Duffin R, Brandenberger C, Murphy F, Rothen-Rutishauser B, et al. Differential effects of long and short carbon nanotubes on the gas-exchange region of the mouse lung. Nanotoxicology. 2012;6:867-79.
55. Birkelbach B, Lutz D, Ruppert C, Henneke I, Lopez-Rodriguez E, Günther A, et al. Linking progression of fibrotic lung remodeling and ultrastructural alterations of alveolar epithelial type II cells in the amiodarone mouse model. Am J Physiol Lung Cell Mol Physiol. 2015;309:63-75.
56. Bratu VA, Erpenbeck VJ, Fehrenbach A, Rausch T, Rittinghausen S, Krug N, et al. Cell counting in human endobronchial biopsies - Disagreement of 2D versus 3D morphometry. PLoS One. 2014;9:1-12.
57. Schneider JP, Ochs M. Alterations of mouse lung tissue dimensions during processing for morphometry: a comparison of methods. Am J Physiol Lung Cell Mol Physiol. 2014;306:341-50.
58. Mühlfeld C, Rothen-Rutishauser B, Vanhecke D, Blank F, Gehr P, Ochs M. Visualization and quantitative analysis of nanoparticles in the respiratory tract by transmission electron microscopy. Part Fibre Toxicol. 2007;4:11.
59. Scherle W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie. 1970;26:57-60.
60. Michel R, Cruz-Orive L. Application of the Cavalieri principle and vertical sections method to lung: estimation of volume and pleural surface area. J Microsc. 1988;150:117-36.
61. Gundersen H, Jensen E. The efficiency of systematic sampling in stereology and its prediction. J Microsc. 1987;147:229-63.
62. Mayhew TM. Taking tissue samples from the placenta: An illustration of principles and strategies. Placenta. 2008;29:1-14.
63. Howard C, Reed M. Unbiased Stereology: Three-Dimensional Measurement in Microscopy. 2nd ed. Abingdon: BIOS Scientific Publishers; 2005.
64. Nyengaard JR, Gundersen HJ. The isector: a simple and direct method for generating isotropic, uniform random sections from small specimens. J Microsc. 1991;165:427-31.
65. Mattfeldt T, Mall G, Gharehbaghi H, Möller P. Estimation of surface area and length with the orientator. J Microsc. 1990;159:301-17.
66. Nyengaard JR, Gundersen HJG. Sampling for stereology in lungs. Eur Respir Rev. 2006;15:107-14.
67. Sterio D. The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc. 1984;134:127-36.
68. Tschanz SA, Burri PH, Weibel ER. A simple tool for stereological assessment of digital images: the STEPanizer. J Microsc. 2011;243:47-59.
69. Gundersen H, Osterby R. Optimizing sampling efficiency of stereological studies in biology: or "do more less well!". J Microsc. 1981;121:65-73.
70. Gundersen HJG, Jensen EBV, Kiêu K, Nielsen J. The efficiency of systematic sampling in stereology - Reconsidered. J Microsc. 1999;193:199-211.
71. Möller W, Kreyling WG, Schmid O, Semmler-Behnke M, Schulz H. Deposition, retention and clearance, and translocation of inhaled fine and nano-sized particles in the respiratory tract. In: Gehr P, Mühlfeld C, Rothen-Ruthishauser B, Blank F, editors. Particle-Lung Interactions. 2nd ed. New York: Informa Healthcare USA; 2010. p. 79-107.
72. Brody AR, Roe M. Deposition pattern of inorganic particles at the alveolar level in the lungs of rats and mice. Am Rev Respir Dis. 1983;128:724-9.
73. Chang LY, Overby LH, Brody AR, Crapo JD. Progressive lung cell reactions and extracellular matrix production after a brief exposure to asbestos. Am J Pathol. 1988;131:156-70.
74. Gardi JE, Nyengaard JR, Gundersen HJG. The proportionator: Unbiased stereological estimation using biased automatic image analysis and non-uniform probability proportional to size sampling. Comput Biol Med. 2008;38:313-28.
75. Keller KK, Andersen IT, Andersen JB, Hahn U, Stengaard-Pedersen K, Hauge EM, et al. Improving efficiency in stereology: A study applying the proportionator and the autodisector on virtual slides. J Microsc. 2013;251:68-76.
76. Gardi JE, Nyengaard JR, Gundersen HJG. Automatic sampling for unbiased and efficient stereological estimation using the proportionator in biological studies. J Microsc. 2008;230:108-20.
77. Schmiedl A, Lempa T, Hoymann HG, Rittinghausen S, Popa D, Tschernig T, et al. Elastase-induced lung emphysema in rats is not reduced by hematopoietic growth factors when applied preventionally. Virchows Arch. 2008;452:675-88.
78. Ochs M, Knudsen L, Allen L, Stumbaugh A, Levitt S, Nyengaard JR, et al. GM-CSF mediates alveolar epithelial type II cell changes, but not emphysema-like pathology, in SP-D-deficient mice. Am J Physiol Lung Cell Mol Physiol. 2004;287:1333-41.
79. Plopper CG, Hyde DM. The non-human primate as a model for studying COPD and asthma. Pulm Pharmacol Ther. 2008;21:755-66.
80. Brandenberger C, Li N, Jackson-Humbles DN, Rockwell CE, Wagner JG, Harkema JR. Enhanced allergic airway disease in old mice is associated with a Th17 response. Clin Exp Allergy. 2014;44:1282-92.
81. Winkler C, Bahlmann O, Viereck J, Knudsen L, Wedekind D, Hoymann HG, et al. Impact of a Met(11)Thr single nucleotide polymorphism of surfactant protein D on allergic airway inflammation in a murine asthma model. Exp Lung Res. 2014;40:154-63.
82. Boyce RW, Dorph-Petersen K-A, Lyck L, Gundersen HJG. Design-based stereology: introduction to basic concepts and practical approaches for estimation of cell number. Toxicol Pathol. 2010;38:1011-25.
83. Howell K, Hopkins N, Mcloughlin P. Combined confocal microscopy and stereology: a highly efficient and unbiased approach to quantitative structural measurement in tissues. Exp Physiol. 2002;87:747-56.
84. Vanhecke D, Studer D, Ochs M. Stereology meets electron tomography: towards quantitative 3D electron microscopy. J Struct Biol. 2007;159:443-50.
85. Kubínová L, Janáĉek J. Confocal microscopy and stereology: Estimating volume, number, surface area and length by virtual test probes applied to three-dimensional images. Microsc Res Tech. 2001;53:425-35.
86. Gundersen HJG. Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. J Microsc. 1977;111:219-23.
87. Churg A, Cosio M, Wright JL. Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am J Physiol Lung Cell Mol Physiol. 2008;294:612-31.
88. Ochs M, Nyengaard JR, Jung A, Knudsen L, Voigt M, Wahlers T, et al. The number of alveoli in the human lung. Am J Respir Crit Care Med. 2004;169:120-4.
89. Hyde DM, Tyler NK, Putney LF, Singh P, Gundersen HJG. Total number and mean size of alveoli in mammalian lung estimated using fractionator sampling and unbiased estimates of the Euler characteristic of alveolar openings. Anat Rec A: Discov Mol Cell Evol Biol. 2004;277:216-26.
90. Gundersen HJG, Boyce RW, Odgaard A. The Conneulor: unbiased estimation of connectivity using physical disectors under projection. Bone. 1993;14:217-22.
91. Brandenberger C, Mühlfeld C, Ali Z, Lenz A-G, Schmid O, Parak WJ, et al. Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles. Small. 2010;6:1669-78.
92. Rothen-Rutishauser B, Kuhn DA, Ali Z, Gasser M, Amin F, Parak WJ, et al. Quantification of gold nanoparticle cell uptake under controlled biological conditions and adequate resolution. Nanomedicine (London). 2014;9:607-21.
93. Brandenberger C, Rothen-Rutishauser B, Blank F, Gehr P, Mühlfeld C. Particles induce apical plasma membrane enlargement in epithelial lung cell line depending on particle surface area dose. Respir Res. 2009;10:22.
94. Mühlfeld C, Mayhew TM, Gehr P, Rothen-Rutishauser B. A novel quantitative method for analyzing the distributions of nanoparticles between different tissue and intracellular compartments. J Aerosol Med. 2007;20:395-407.
95. Brandenberger C, Clift MJD, Vanhecke D, Mühlfeld C, Stone V, Gehr P, et al. Intracellular imaging of nanoparticles: is it an elemental mistake to believe what you see? Part Fibre Toxicol. 2010;7:15.
96. Hyde DM, Tyler NK, Plopper CG. Morphometry of the respiratory tract: avoiding the sampling, size, orientation, and reference traps. Toxicol Pathol. 2007;35:41-8.
97. Braendgaard H, Gundersen HJG. The impact of recent stereological advances on quantitative studies of the nervous system. J Neurosci Methods. 1986;18:39-78.
98. Dorph-Petersen KA, Nyengaard JR, Gundersen HJG. Tissue shrinkage and unbiased stereological estimation of particle number and size. J Microsc. 2001;204:232-46.
99. Jeffery P, Holgate S, Wenzel S. Methods for the assessment of endobronchial biopsies in clinical research: Application to studies of pathogenesis and the effects of treatment. Am J Respir Crit Care Med. 2003;168:1-17.
100. Woodruff PG, Dolganov GM, Ferrando RE, Donnelly S, Hays SR, Solberg OD, et al. Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med. 2004;169:1001-6.
101. Regamey N, Ochs M, Hilliard TN, Mühlfeld C, Cornish N, Fleming L, et al. Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2008;177:837-43.